329 related articles for article (PubMed ID: 26848522)
1. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.
Zhang Y; Liu J; Lin J; Zhou L; Song Y; Wei B; Luo X; Chen Z; Chen Y; Xiong J; Xu X; Ding L; Ye Q
Oncotarget; 2016 Mar; 7(9):9859-75. PubMed ID: 26848522
[TBL] [Abstract][Full Text] [Related]
2. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract][Full Text] [Related]
3. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
4. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
5. Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions.
Ma J; Xue Y; Cui W; Li Y; Zhao Q; Ye W; Zheng J; Cheng Y; Ma Y; Li S; Han T; Miao L; Yao L; Zhang J; Liu W
Cancer; 2012 Sep; 118(17):4105-16. PubMed ID: 22907703
[TBL] [Abstract][Full Text] [Related]
6. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
8. Control of VEGF expression in triple-negative breast carcinoma cells by suppression of SAF-1 transcription factor activity.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2011 Aug; 9(8):1030-41. PubMed ID: 21665940
[TBL] [Abstract][Full Text] [Related]
9. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
Ray A; Alalem M; Ray BK
J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
11. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
12. SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer.
Song Y; Zhang J; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Tumour Biol; 2016 Jul; 37(7):9311-22. PubMed ID: 26779630
[TBL] [Abstract][Full Text] [Related]
13. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
Chen X; Meng Q; Zhao Y; Liu M; Li D; Yang Y; Sun L; Sui G; Cai L; Dong X
Cancer Lett; 2013 Jan; 328(2):318-24. PubMed ID: 23092556
[TBL] [Abstract][Full Text] [Related]
15. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.
Yu W; Chai H; Li Y; Zhao H; Xie X; Zheng H; Wang C; Wang X; Yang G; Cai X; Falck JR; Yang J
Toxicol Appl Pharmacol; 2012 Oct; 264(1):73-83. PubMed ID: 22841774
[TBL] [Abstract][Full Text] [Related]
18. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
19. Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.
Yu X; Li W; Deng Q; You S; Liu H; Peng S; Liu X; Lu J; Luo X; Yang L; Tang M; Weng X; Yi W; Liu W; Wu S; Ding Z; Feng T; Zhou J; Fan J; Bode AM; Dong Z; Liu J; Cao Y
Mol Carcinog; 2017 May; 56(5):1414-1426. PubMed ID: 27996164
[TBL] [Abstract][Full Text] [Related]
20. Human Adipose-Derived Mesenchymal Stem Cell-Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis.
Wang Y; Liu J; Jiang Q; Deng J; Xu F; Chen X; Cheng F; Zhang Y; Yao Y; Xia Z; Xu X; Su X; Huang M; Dai L; Yang Y; Zhang S; Yu D; Zhao RC; Wei Y; Deng H
Stem Cells; 2017 Sep; 35(9):2060-2070. PubMed ID: 28514506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
